O'Shaughnessy Asset Management, LLC Fibrogen Inc Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$9.93 - $15.39 $40,166 - $62,252	-4,045 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$10.18 - $26.64 $3,461 - $9,057	-340 Reduced 7.75%	4,045 $41,000
Q2 2021 Aug 09, 2021	BUY	$18.57 - $35.68 $32,608 - $62,654	1,756 Added 66.79%	4,385 $117,000
Q4 2020 Feb 11, 2021	BUY	$37.09 - $48.97 $97,509 - $128,742	2,629 New	2,629 $97,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.